Making espresso literally boils down to two major components: extremely hot water and high pressure. Add up the world’s ...

As India’s asset management industry continues to deepen, the expectations placed on investment managers are changing. Investors are no longer focused only on access to products or headline returns.

AO recently became the first retailer globally to pass 1 million Trustpilot reviews with a 4.9/5 rating, which the brand’s customer director says helps drive differentiation, loyalty and growth in a ...

GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today released financial results for the first quarter ended May 2, 2026. The Company’s condensed and consolidated financial statements, ...

Lucas signed the National Enforcement Plan for Fiscal Years 2025-2029 (the NEP), formally replacing the Biden-era Strategic Enforcement Plan for Fiscal Years 2024-2028 (the SEP). Although the NEP ...

Well, good morning, everyone, and welcome to Cullinan Therapeutics Immunology Day. Today is an important milestone for Cullinan and also the way autoimmune diseases may be treated in the future. As ...

Dana Incorporated (NYSE: DAN) today announced it has entered into a definitive agreement with Eaton Corporation plc (NYSE: ...

Korean researchers have developed a new catalyst design technology that can improve the performance of batteries and hydrogen ...

Design is a strategic tool that shapes perception, influences emotional response, and ultimately determines market value. Luxury properties are not purchased solely for square footage or location; ...

First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 ...

Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer ” or the “Company ”), a world-leading technology company for AI and Bitcoin mining infrastructure, today released its unaudited financial results ...

Anticipated pipeline milestones over next six months include obtaining 24-week biomarker and clinical data from Phase 2a trial evaluating neflamapimod in nonfluent variant primary progressive aphasia ...